Daratumumab, bortezomib, lenalidomide, and dexamethasone in TE NDMM: PERSEUS/GRIFFIN pooled analysis of patients ≥65 years Meeting Abstract


Authors: Sonneveld, P.; Rodríguez-Otero, P.; Voorhees, P. M.; Boccadoro, M.; Laubach, J.; Einsele, H.; Sborov, D.; Dimopoulos, M. A.; Broijl, A.; Mina, R.; Spencer, A.; Schjesvol, F.; Silberman, R.; Gay, F.; Costa, L. J.; Perrot, A.; Liu, Y.; Wang, J.; Sitthi-Amorn, A.; Carson, R.; Cortoos, A.; Usmani, S. Z.; Richardson, P. G.; Moreau, P.; Kaufman, J. L.
Abstract Title: Daratumumab, bortezomib, lenalidomide, and dexamethasone in TE NDMM: PERSEUS/GRIFFIN pooled analysis of patients ≥65 years
Meeting Title: 65th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 206
Issue: Suppl. 1
Meeting Dates: 2025 Apr 27-29
Meeting Location: Glasgow, Scotland
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2025-04-01
Language: English
ACCESSION: WOS:001517858300344
PROVIDER: wos
DOI: 10.1111/bjh.20117
Notes: Meeting Abstract: PO69 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    343 Usmani